跳至主要内容
临床试验/NCT05751746
NCT05751746招募中不适用

The Effect of Peripartum Magnesium Sulfate Use on the Occurrence of Postpartum Depression

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2023年1月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
108
试验地点
1
主要终点
postpartum depression

研究概览

简要总结

This is an observational study that will be conducted on pregnant women under vaginal delivery or cesarean section. The magnesium sulfate will be given to appropriate participants with a protocol that obstetrician are already using in our hospital. After delivery, participants are asked to answer sequential questionnaires to assess postpartum depression.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women who will do delivery.
  • Gestational week >= 30 week
  • Singleton

排除标准

  • History of depression

研究组 & 干预措施

Magnesium group

Intervention group with participants who get magnesium sulfate administration.

干预措施: Magnesium sulfate (Drug)

结局指标

主要结局

postpartum depression

时间窗: 6 week after discharge

depression diagnosis using K-EPDS(Korean version of Edinburgh Postnatal Depression Scale) on a scale of 7 to 30 points.

postpartum depression severity

时间窗: 6 week after discharge

depression severity using K-EPDS; mild (7\~13 points), moderate (14\~19 points), severe (20\~30 points)

次要结局

  • postpartum depression(2week after discharge)
  • postpartum depression severity(2 week after discharge)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验